Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Phillip H. Lam"'
Autor:
Charles O. Faselis, Gregg C. Fonarow, Farooq H. Sheikh, Shalini D. Allam, Prakash Deedwania, Cherinne Arundel, Ali Ahmed, Wilbert S. Aronow, Poonam Bhyan, Venkatesh K. Raman, Phillip H. Lam, Samir S. Patel, Ioannis Kanonidis, Richard M. Allman, Apostolos Tsimploulis
Publikováno v:
The American Journal of Medicine. 135:737-744
Background In patients with heart failure with reduced ejection fraction (HFrEF) and hypertension, systolic blood pressure is recommended to be maintained below 130 mmHg, although this has not been shown to be associated with improved outcomes. We ex
Autor:
Charles Faselis, Richard M. Allman, Helen Sheriff, Robert Enders, Essraa Bayoumi, Phillip H. Lam, Ali Ahmed, Cherinne Arundel, Prakash Deedwania, Vijaywant Brar, Gregg C. Fonarow, Corrine Y Jurgens
Publikováno v:
The American Journal of Medicine. 135:607-614
Background: Beta-blockers improve clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF). Less is known about their role in older nursing home residents with HFrEF. Methods: From the combined OPTIMIZE-HF and Alabama H
Autor:
Farooq H. Sheikh, Amiya A Ahmed, Gregg C. Fonarow, Ali Ahmed, Lowell Safren, C Morgan, Vijaywant Brar, Kannayiram Alagiakrishnan, Phillip H. Lam, Charles Faselis, Prakash Deedwania, Richard M. Allman
Publikováno v:
Progress in Cardiovascular Diseases. 71:92-99
To examine the association between income and cardiovascular disease (CVD) in community-dwelling older adults.Of the 5795 Medicare-eligible community-dwelling older Americans aged 65-100 years in the Cardiovascular Health Study (CHS), 4518 (78%) were
Autor:
Tran Nguyen, Phillip H. Lam, Gerasimos Filippatos, Samuel Wopperer, Ali Ahmed, Cherinne Arundel, Charles Faselis, Samir S. Patel, Gregg C. Fonarow, Prakash Deedwania, Richard M. Allman, Michael R. Zile
Publikováno v:
The American Journal of Medicine. 134:797-804
The effect of loop diuretics on clinical outcomes in heart failure has not been evaluated in randomized controlled trials. In hospitalized patients with heart failure, a discharge loop diuretic prescription has been shown to be associated with improv
Autor:
Phillip H. Lam, Prakash Deedwania, Michael R. Zile, Wilbert S. Aronow, Poonam Bhyan, Charles Faselis, Richard M. Allman, Apostolos Tsimploulis, Charity J. Morgan, Samir S. Patel, Cherinne Arundel, Deepak L. Bhatt, Qing Zeng-Trietler, Ali Ahmed, Gregg C. Fonarow, Peter Kokkinos
Publikováno v:
Am J Med
BACKGROUND: New hypertension and heart failure guidelines recommend that systolic blood pressure (SBP) in patients with heart failure with preserved ejection fraction (HFpEF) and hypertension be lowered to
Autor:
Charity J. Morgan, Hans Moore, Markus S. Anker, Cherinne Arundel, Prakash Deedwania, Richard M. Allman, Samuel Wopperer, Steven N. Singh, Charles Faselis, Gregg C. Fonarow, Qing Zeng, Phillip H. Lam, Lakshmi Tummala, Pamela Karasik, Ali Ahmed
Publikováno v:
The American Journal of Medicine. 133:1460-1470
Background Digoxin reduces the risk of heart failure hospitalization but has no effect on mortality in patients with heart failure without atrial fibrillation in the randomized controlled trial setting. Observational studies of digoxin use in patient
Autor:
Cherinne Arundel, Milton Packer, Steven N. Singh, Yan Cheng, Wayne C. Levy, Richard M. Allman, Vijaywant Brar, Wen-Chih Wu, Gregg C. Fonarow, Phillip H. Lam, Michael R. Zile, Ali Ahmed, Gauravpal S. Gill
Publikováno v:
The American Journal of Medicine. 133:1187-1194
Background Digoxin reduces the risk of heart failure hospitalization in patients with heart failure with reduced ejection fraction. Less is known about this association in patients with heart failure with preserved ejection fraction (HFpEF), the exam
Autor:
Cherinne Arundel, Charles Faselis, Phillip H. Lam, Selma F. Mohammed, Charity J. Morgan, Linda G. Jones, Gregg C. Fonarow, Richard M. Allman, Helen Sheriff, Corrine Y. Jurgens, Ali Ahmed
Publikováno v:
American Journal of Therapeutics. 27:e235-e242
Background Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs-ARBs) improve outcomes in heart failure (HF). Less is known about this association in nursing home (NH) residents. Methods Of the 8024 hospitalized HF patient
Autor:
Gregg C. Fonarow, Richard M. Allman, Ali Ahmed, Phillip H. Lam, Daniel J. Dooley, Charity J. Morgan, Cherinne Arundel, Deepak L. Bhatt
Publikováno v:
The American Journal of Cardiology. 123:1840-1844
Heart failure (HF) is the leading cause for 30-day all-cause readmission in older Medicare beneficiaries and 30-day all-cause readmission is associated with a higher risk of mortality. In the current analysis, we examined if that association varied b
Autor:
Bertram Pitt, Prakash Deedwania, Gregg C. Fonarow, Ali Ahmed, Charity J. Morgan, Deepak L. Bhatt, Neha Gupta, Steven N. Singh, Michael R. Zile, Phillip H. Lam, Daniel J. Dooley
Publikováno v:
The American Journal of Medicine. 131:1473-1481
Background Beta-blockers in high target doses are recommended for heart failure with reduced ejection fraction (HFrEF) but not for preserved ejection fraction (HFpEF). Treatment benefits are often more pronounced in high-risk subgroups, and patients